Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source

Source document· December 8, 2025

HUTCHMED Announces Expanded Coverage on National Reimbursement Drug List and Inclusion in the First Commercial Insurance Drug List in China

View original at globenewswire.com

HUTCHMED Announces Expanded Coverage on National Reimbursement Drug List and Inclusion in the First Commercial Insurance Drug List in China HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Dec…

Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

The Commercial Insurance Drug List together with the NRDL forms a key component of China's multi-level medical insurance system
80% confidence
1.33 billion people in China had basic medical insurance coverage as of end of 2024, representing around 95% of the entire population
80% confidence
The multi-layered reimbursement framework enhances patient access to breakthrough treatments while supporting sustainable development of China's innovative pharmaceutical sector
80% confidence